BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17363465)

  • 1. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine.
    De Lisle RC
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G104-11. PubMed ID: 17363465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
    De Lisle RC; Roach E; Jansson K
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype.
    De Lisle RC; Mueller R; Roach E
    BMC Gastroenterol; 2010 Sep; 10():107. PubMed ID: 20843337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse.
    De Lisle RC; Meldi L; Roach E; Flynn M; Sewell R
    PLoS One; 2009; 4(1):e4283. PubMed ID: 19172182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.
    Norkina O; Burnett TG; De Lisle RC
    Infect Immun; 2004 Oct; 72(10):6040-9. PubMed ID: 15385508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine.
    de Lisle RC; Sewell R; Meldi L
    Neurogastroenterol Motil; 2010 Mar; 22(3):341-e87. PubMed ID: 19814773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation.
    De Lisle RC; Roach EA; Norkina O
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):46-52. PubMed ID: 16385253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
    Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
    J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal smooth muscle dysfunction develops postnatally in cystic fibrosis mice.
    De Lisle RC; Meldi L; Mueller R
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):689-94. PubMed ID: 22699839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal transit times and motility in patients with cystic fibrosis.
    Hedsund C; Gregersen T; Joensson IM; Olesen HV; Krogh K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):920-6. PubMed ID: 22746323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
    Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
    Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
    Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
    Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis.
    Lisowska A; Madry E; Pogorzelski A; Szydłowski J; Radzikowski A; Walkowiak J
    Scand J Clin Lab Invest; 2010 Sep; 70(5):322-6. PubMed ID: 20560844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed Gastric Emptying Is Not Associated with a Microbiological Diagnosis of Small Intestinal Bacterial Overgrowth.
    Calderon G; Siwiec RM; Bohm ME; Nowak TV; Wo JM; Gupta A; Xu H; Shin A
    Dig Dis Sci; 2021 Jan; 66(1):160-166. PubMed ID: 32124195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered intestinal motility in leptin-deficient obese mice.
    Kiely JM; Noh JH; Graewin SJ; Pitt HA; Swartz-Basile DA
    J Surg Res; 2005 Mar; 124(1):98-103. PubMed ID: 15734486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3.
    McHugh DR; Cotton CU; Moss FJ; Vitko M; Valerio DM; Kelley TJ; Hao S; Jafri A; Drumm ML; Boron WF; Stern RC; McBennett K; Hodges CA
    Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G868-G878. PubMed ID: 30118317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse.
    De Lisle RC; Mueller R; Boyd M
    J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):371-9. PubMed ID: 21970994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Expression of Enterocyte Nutrient Assimilation Genes and Proteins in the Small Intestine of Cystic Fibrosis Mouse.
    De Lisle RC
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):627-34. PubMed ID: 26551319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged orocecal transit time enhances serum bile acids through bacterial overgrowth, contributing factor to gallstone disease.
    Kaur J; Rana SV; Gupta R; Gupta V; Sharma SK; Dhawan DK
    J Clin Gastroenterol; 2014 Apr; 48(4):365-9. PubMed ID: 24598592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model.
    Bazett M; Bergeron ME; Haston CK
    Sci Rep; 2016 Jan; 6():19189. PubMed ID: 26754178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.